Matches in SemOpenAlex for { <https://semopenalex.org/work/W2335498506> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2335498506 endingPage "22" @default.
- W2335498506 startingPage "918" @default.
- W2335498506 abstract "Angiotensin II (AII) acts by 2 types of receptors: the ATI receptor which mediates its actions on vasoconstriction, renin (inhibition) and aldosterone (stimulation) secretions, cellular proliferation and angiogenesis and the non-AT1 (often called AT2) receptors. Mainly expressed in the embryon these latter may favor cellular differentiation and recruitment of collateral circulation. Angiotensin converting enzyme inhibitors (ACEI) decrease the synthesis of All and therefore the stimulation of both receptor types whereas AT1-receptor antagonists (AT1RA) block only the stimulation of these latter and increase the stimulation of AT2 receptor since they increase the production of All secondarily to the inhibition of the feedback of renin secretion by All. Experimentally ACEI and AT1RA decrease angiogenesis and cellular proliferation and favor cellular differentiation which could explain the protective effect of ACEI against cancer suggested recently in a Scotish study. Despite of their common suppressive effect on angiogenesis AT1RA may better than ACEI protect against ischemic events specially the cerebral ones because they favor the rapid recruitment of collateral circulation. This has been demonstrated for losartan in case of abrupt ligation of the carotid in the gerbil since its previous administration protects against fatal cerebral ischemia whereas its previous administration with enalapril abolishes this protection. These data may explain why, in the CAPP trial, captopril which has prevented more effectively diabetes occurrence could not be proved superior to diuretics and/or betablocker in the prevention of myocardial infarction and specially of strokes for which exist on the contrary a suspicion of a lower protection. Therefore a comparative trial between AT1RA and ACEI in the prevention of stroke recurrence should appear as a priority for Public Health and Pharmaceutical Industry Authorities." @default.
- W2335498506 created "2016-06-24" @default.
- W2335498506 creator A5022609341 @default.
- W2335498506 creator A5040358254 @default.
- W2335498506 creator A5043803342 @default.
- W2335498506 creator A5068090555 @default.
- W2335498506 creator A5068435270 @default.
- W2335498506 creator A5071062752 @default.
- W2335498506 creator A5077967128 @default.
- W2335498506 creator A5078006856 @default.
- W2335498506 date "1999-06-09" @default.
- W2335498506 modified "2023-09-23" @default.
- W2335498506 title "[Duality of angiotensin II receptors and risk for stroke and cancer: what is the connection?]." @default.
- W2335498506 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10360191" @default.
- W2335498506 hasPublicationYear "1999" @default.
- W2335498506 type Work @default.
- W2335498506 sameAs 2335498506 @default.
- W2335498506 citedByCount "1" @default.
- W2335498506 crossrefType "journal-article" @default.
- W2335498506 hasAuthorship W2335498506A5022609341 @default.
- W2335498506 hasAuthorship W2335498506A5040358254 @default.
- W2335498506 hasAuthorship W2335498506A5043803342 @default.
- W2335498506 hasAuthorship W2335498506A5068090555 @default.
- W2335498506 hasAuthorship W2335498506A5068435270 @default.
- W2335498506 hasAuthorship W2335498506A5071062752 @default.
- W2335498506 hasAuthorship W2335498506A5077967128 @default.
- W2335498506 hasAuthorship W2335498506A5078006856 @default.
- W2335498506 hasConcept C104849204 @default.
- W2335498506 hasConcept C123915805 @default.
- W2335498506 hasConcept C126322002 @default.
- W2335498506 hasConcept C134018914 @default.
- W2335498506 hasConcept C170493617 @default.
- W2335498506 hasConcept C198710026 @default.
- W2335498506 hasConcept C24998067 @default.
- W2335498506 hasConcept C2778525890 @default.
- W2335498506 hasConcept C2780288358 @default.
- W2335498506 hasConcept C2780394083 @default.
- W2335498506 hasConcept C2908929049 @default.
- W2335498506 hasConcept C541997718 @default.
- W2335498506 hasConcept C71924100 @default.
- W2335498506 hasConcept C84393581 @default.
- W2335498506 hasConcept C98274493 @default.
- W2335498506 hasConceptScore W2335498506C104849204 @default.
- W2335498506 hasConceptScore W2335498506C123915805 @default.
- W2335498506 hasConceptScore W2335498506C126322002 @default.
- W2335498506 hasConceptScore W2335498506C134018914 @default.
- W2335498506 hasConceptScore W2335498506C170493617 @default.
- W2335498506 hasConceptScore W2335498506C198710026 @default.
- W2335498506 hasConceptScore W2335498506C24998067 @default.
- W2335498506 hasConceptScore W2335498506C2778525890 @default.
- W2335498506 hasConceptScore W2335498506C2780288358 @default.
- W2335498506 hasConceptScore W2335498506C2780394083 @default.
- W2335498506 hasConceptScore W2335498506C2908929049 @default.
- W2335498506 hasConceptScore W2335498506C541997718 @default.
- W2335498506 hasConceptScore W2335498506C71924100 @default.
- W2335498506 hasConceptScore W2335498506C84393581 @default.
- W2335498506 hasConceptScore W2335498506C98274493 @default.
- W2335498506 hasIssue "17" @default.
- W2335498506 hasLocation W23354985061 @default.
- W2335498506 hasOpenAccess W2335498506 @default.
- W2335498506 hasPrimaryLocation W23354985061 @default.
- W2335498506 hasRelatedWork W1966128948 @default.
- W2335498506 hasRelatedWork W1974641745 @default.
- W2335498506 hasRelatedWork W2000877933 @default.
- W2335498506 hasRelatedWork W2004844722 @default.
- W2335498506 hasRelatedWork W2030024444 @default.
- W2335498506 hasRelatedWork W2038571733 @default.
- W2335498506 hasRelatedWork W2111190158 @default.
- W2335498506 hasRelatedWork W2118736985 @default.
- W2335498506 hasRelatedWork W2132612653 @default.
- W2335498506 hasRelatedWork W4250609719 @default.
- W2335498506 hasVolume "28" @default.
- W2335498506 isParatext "false" @default.
- W2335498506 isRetracted "false" @default.
- W2335498506 magId "2335498506" @default.
- W2335498506 workType "article" @default.